Expanded Hemodialysis Therapy Market Outlook:
Expanded Hemodialysis Therapy Market size was valued at USD 95.07 billion in 2025 and is set to exceed USD 153.39 billion by 2035, expanding at over 4.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of expanded hemodialysis therapy is evaluated at USD 99.26 billion.
The major factor for market growth is the rising cases of chronic kidney diseases among the global population. As the failure of kidneys halts the process of cleaning blood and waste outflow, it requires the external help of advanced medical devices for filtering the blood. Thus, the rising chronic kidney diseases around the world are anticipated to bring in lucrative growth opportunities for market expansion during the forecast period. As per the estimations, about 11% of the world’s population was suffering from chronic kidney disease in 2022.
With the rising shift of people towards a sedentary lifestyle, there has been a significant increase in lifestyle disorders such as diabetes and hypertension. Escalation in such diseases leads to blood disorders which in turn is estimated to create a positive outlook for market growth during the analysis period. Along with that, the rising technological advancement in the field of healthcare and medicine is attributed to propel the development of novel medical products and is expected to aid the development of the global expanded hemodialysis therapy market in the upcoming years. Also, the rising cases of chronic diseases and acute disorders coupled with the rising prevalence of rare diseases is anticipated to drive market growth in the upcoming years. In addition to other factors, the increasing cases of end-stage renal disease (ESRD) and other kidney-related diseases are expected to increase the demand for dialysis and expanded hemodialysis therapy to maintain proper kidney functioning which in turn is projected to expand the market size during the forecast period.
